Revolution Medicines, Inc.
← Back to RVMD Overview

Revolution Medicines, Inc. (RVMD)

Solvency & Capital Structure

Total Debt

$437.3M

Net Debt

-$1.47B

Revolution Medicines, Inc. currently has $437.3M in total debt. Net debt is -$1.47B after cash offsets. This 'Net Cash' position indicates exceptional financial strength.

Financial Fundamentals

RVMDQuarterly Data • 5Y View

DateTotal Debt ($B)Cash & Inv. ($B)Net Debt ($B)Total AssetsDebt/Assets
2026-03-310.441.91-1.47Net Cash2.2519.4%
2025-12-310.162.03-1.87Net Cash2.356.7%
2025-09-300.161.93-1.77Net Cash2.257.0%
2025-06-300.132.14-2.00Net Cash2.435.5%
2025-03-310.132.10-1.97Net Cash2.375.7%
2024-12-310.142.29-2.15Net Cash2.565.3%
2024-09-300.091.55-1.46Net Cash1.764.9%
2024-06-300.091.59-1.50Net Cash1.814.8%
2024-03-310.091.70-1.62Net Cash1.914.6%
2023-12-310.091.85-1.77Net Cash2.064.3%
2023-09-300.060.81-0.75Net Cash0.986.4%
2023-06-300.060.91-0.85Net Cash1.075.9%
2023-03-310.060.91-0.85Net Cash1.075.9%
2022-12-310.060.64-0.58Net Cash0.817.9%
2022-09-300.070.66-0.59Net Cash0.837.9%
2022-06-300.060.46-0.40Net Cash0.6310.3%
2022-03-310.070.52-0.45Net Cash0.689.7%
2021-12-310.070.58-0.51Net Cash0.749.0%
2021-09-300.030.61-0.58Net Cash0.734.3%
2021-06-300.030.65-0.61Net Cash0.774.2%
2021-03-310.030.68-0.65Net Cash0.813.9%
2020-12-310.030.44-0.41Net Cash0.575.8%
2020-09-300.030.47-0.43Net Cash0.605.6%
2020-06-300.030.33-0.29Net Cash0.457.5%
2020-03-310.010.35-0.34Net Cash0.452.4%
2019-12-310.000.12-0.12Net Cash0.220.0%
2019-09-300.000.14-0.14Net Cash0.230.1%
2019-03-310.000.07-0.07Net Cash0.00
2018-12-310.000.07-0.07Net Cash0.170.1%